Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: A systematic review

Journal of Hospital Infection

Volumn 78, Issue 3, 2011, Pages 171-177

  Falagas, M E ^a,b,c   Thomaidis, P C ^a   Kotsantis, I K ^a   Sgouros, K ^a   Samonis, G ^a,d   Karageorgopoulos, D E ^a  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b HENRY DUNANT HOSPITAL   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Cross infection; Disinfectants; Infection control; Intensive care units; Nosocomial infections; Sterilisation

Indexed keywords

HYDROGEN PEROXIDE;

BACTERIUM CONTAMINATION; CLOSTRIDIUM DIFFICILE; DISINFECTION; HOSPITAL; HOSPITAL INFECTION; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; POLLUTION; REVIEW; VAPOR;

AEROSOLS; BACTERIA; BACTERIAL LOAD; CROSS INFECTION; DISEASE OUTBREAKS; DISINFECTANTS; DISINFECTION; ENVIRONMENTAL MICROBIOLOGY; HOSPITALS; HUMANS; HYDROGEN PEROXIDE; INFECTION CONTROL; MICROBIAL VIABILITY;

EID: 79958738877     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2010.12.006     Document Type: Review

References (35)

1. Karageorgopoulos D.E., Falagas M.E. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008, 8:751-762.
2. Boyce J.M., Potter-Bynoe G., Chenevert C., King T. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 1997, 18:622-627.
3. McFarland L.V., Mulligan M.E., Kwok R.Y., Stamm W.E. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989, 320:204-210.
4. Kramer A., Schwebke I., Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006, 6:130.
5. Bhalla A., Pultz N.J., Gries D.M., et al. Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients. Infect Control Hosp Epidemiol 2004, 25:164-167.
6. Hota B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection?. Clin Infect Dis 2004, 39:1182-1189.
7. Pittet D., Dharan S., Touveneau S., Sauvan V., Perneger T.V. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med 1999, 159:821-826.
8. Dancer S.J. The role of environmental cleaning in the control of hospital-acquired infection. J Hosp Infect 2009, 73:378-385.
9. Hardy K.J., Oppenheim B.A., Gossain S., Gao F., Hawkey P.M. A study of the relationship between environmental contamination with methicillin-resistant Staphylococcus aureus (MRSA) and patients' acquisition of MRSA. Infect Control Hosp Epidemiol 2006, 27:127-132.
10. Jarvis W.R. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 1996, 17:552-557.
11. White L.F., Dancer S.J., Robertson C. A microbiological evaluation of hospital cleaning methods. Int J Environ Health Res 2007, 17:285-295.
12. Rutala W.A., Weber D.J. New disinfection and sterilization methods. Emerg Infect Dis 2001, 7:348-353.
13. Rutala WA, Weber DJ, and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for disinfection and sterilization in healthcare facilities, 2008.
14. Bartels M.D., Kristoffersen K., Slotsbjerg T., Rohde S.M., Lundgren B., Westh H. Environmental meticillin-resistant Staphylococcus aureus (MRSA) disinfection using dry-mist-generated hydrogen peroxide. J Hosp Infect 2008, 70:35-41.
15. Otter J.A., Cummins M., Ahmad F., van Tonder C., Drabu Y.J. Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination. J Hosp Infect 2007, 67:182-188.
16. Jeanes A., Rao G., Osman M., Merrick P. Eradication of persistent environmental MRSA. J Hosp Infect 2005, 61:85-86.
17. Dryden M., Parnaby R., Dailly S., et al. Hydrogen peroxide vapour decontamination in the control of a polyclonal meticillin-resistant Staphylococcus aureus outbreak on a surgical ward. J Hosp Infect 2008, 68:190-192.
18. Hardy K.J., Gossain S., Henderson N., et al. Rapid recontamination with MRSA of the environment of an intensive care unit after decontamination with hydrogen peroxide vapour. J Hosp Infect 2007, 66:360-368.
19. French G.L., Otter J.A., Shannon K.P., Adams N.M., Watling D., Parks M.J. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect 2004, 57:31-37.
20. Bates C.J., Pearse R. Use of hydrogen peroxide vapour for environmental control during a Serratia outbreak in a neonatal intensive care unit. J Hosp Infect 2005, 61:364-366.
21. Shapey S., Machin K., Levi K., Boswell T.C. Activity of a dry mist hydrogen peroxide system against environmental Clostridium difficile contamination in elderly care wards. J Hosp Infect 2008, 70:136-141.
22. Boyce J.M., Havill N.L., Otter J.A., et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol 2008, 29:723-739.
23. Barbut F., Menuet D., Verachten M., Girou E. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol 2009, 30:507-514.
24. Klapes N.A., Vesley D. Vapor-phase hydrogen peroxide as a surface decontaminant and sterilant. Appl Environ Microbiol 1990, 56:503-506.
25. Grare M., Dailloux M., Simon L., Dimajo P., Laurain C. Efficacy of dry mist of hydrogen peroxide (DMHP) against Mycobacterium tuberculosis and use of DMHP for routine decontamination of biosafety level 3 laboratories. J Clin Microbiol 2008, 46:2955-2958.
26. Hall L., Otter J.A., Chewins J., Wengenack N.L. Use of hydrogen peroxide vapor for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room. J Clin Microbiol 2007, 45:810-815.
27. Johnston M.D., Lawson S., Otter J.A. Evaluation of hydrogen peroxide vapour as a method for the decontamination of surfaces contaminated with Clostridium botulinum spores. J Microbiol Methods 2005, 60:403-411.
28. Otter J.A., French G.L. Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapor. J Clin Microbiol 2009, 47:205-207.
29. Bernard A. Chlorination products: emerging links with allergic diseases. Curr Med Chem 2007, 14:1771-1782.
30. Vincent G., Kopferschmitt-Kubler M.C., Mirabel P., Pauli G., Millet M. Sampling and analysis of quaternary ammonium compounds (QACs) traces in indoor atmosphere. Environ Monit Assess 2007, 133:25-30.
31. McDonnell G. Hydrogen peroxide fogging/fumigation. J Hosp Infect 2006, 62:385-386.
32. Otter J.A., French G.L., Adams N.M.T., Watling D., Parks M.J. Hydrogen peroxide vapour decontamination in an overcrowded tertiary care referral centre: some practical answers. J Hosp Infect 2006, 62:384-385.
33. Rutala W.A., Weber D.J. Disinfection and sterilization in health care facilities: what clinicians need to know. Clin Infect Dis 2004, 39:702-709.
34. Andersen B.M., Rasch M., Hochlin K., Jensen F.H., Wismar P., Fredriksen J.E. Decontamination of rooms, medical equipment and ambulances using an aerosol of hydrogen peroxide disinfectant. J Hosp Infect 2006, 62:149-155.
35. Otter J.A., Puchowicz M., Ryan D., et al. Feasibility of routinely using hydrogen peroxide vapor to decontaminate rooms in a busy United States hospital. Infect Contr Hosp Epidemiol 2009, 30:574-577.